GB Sciences Company Description

GB Sciences, Inc., a plant-based research and biopharmaceutical drug development company.

The company offers cannabis inspired medicines and complex therapeutic mixtures for the prescription drug market.

Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson’s disease, neuropathic pain, chronic pain, cytokine release syndrome, stress/anxiety/depression, and cardiovascular therapeutic programs.

The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016.

GB Sciences, Inc. is based in Las Vegas, Nevada.

GB Sciences, Inc.

Country	United States
Founded	2001
Industry	Biotechnology
Sector	Healthcare
Employees	2

Contact Details

Address: 9205 W. Russell Road Las Vegas, Nevada 89148 United States
Phone	866-721-0297
Website	gbsciences.com

Stock Details

Ticker Symbol	GBLX
Exchange	OTCMKTS
Fiscal Year	April - March
Reporting Currency	USD
ISIN Number	US3615441090
SIC Code	2834

Key Executives

Name	Position
Dr. Andrea Small-Howard M.B.A., MBA, Ph.D.	Chairman of Scientific Advisory Board, Chief Science Officer, President and Director
Gary R. Henrie Esq.	Securities Counsel and Company Secretary